Sequenom Inc., a prominent player in the biotechnology industry, is headquartered in the United States. Founded in 1994, the company has established itself as a leader in non-invasive prenatal testing (NIPT) and molecular diagnostics. With a focus on advancing genetic testing technologies, Sequenom offers innovative products such as the MaterniT21 PLUS test, which provides expectant parents with critical information about their baby's health. The company operates primarily in North America, with significant influence in the global market for genetic testing. Sequenom's commitment to research and development has led to numerous milestones, including the introduction of cutting-edge assays that enhance the accuracy and reliability of genetic screening. Recognised for its pioneering contributions, Sequenom continues to shape the future of prenatal care and diagnostics, solidifying its position as a trusted name in the industry.
How does Sequenom Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Sequenom Inc.'s score of 69 is higher than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Sequenom Inc., headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Labcorp Holdings Inc., which may influence its climate commitments and reporting practices. As part of its corporate family relationship, Sequenom Inc. inherits climate initiatives and targets from Labcorp Holdings Inc. However, there are no documented reduction targets or significant climate pledges available for Sequenom at this time. This lack of specific data suggests that Sequenom may be aligning its sustainability efforts with those of its parent company, Labcorp, which is known for its commitment to reducing carbon emissions and enhancing environmental sustainability. In summary, while Sequenom Inc. does not provide specific emissions data or reduction targets, it is positioned within a corporate structure that may support broader climate initiatives through its association with Labcorp Holdings Inc.
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2018 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 69,115,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 178,899,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | 000,000,000 | 0,000,000,000 | 000,000,000 | 0,000,000,000 | 0,000,000,000 |
Sequenom Inc.'s Scope 3 emissions, which decreased by 4% last year and increased by approximately 10% since 2020, demonstrating supply chain emissions tracking. Most of their carbon footprint comes from suppliers and value chain emissions, with Scope 3 emissions accounting for 76% of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 54% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Sequenom Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.